Chambers James J, Nichols David E
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907-1333, USA.
J Comput Aided Mol Des. 2002 Jul;16(7):511-20. doi: 10.1023/a:1021275430021.
A homology-based model of the 5-HT2A receptor was produced utilizing an activated form of the bovine rhodopsin (Rh) crystal structure. In silico activation of the Rh structure was accomplished by isomerization of the 11-cis-retinal (1) chromophore, followed by constrained molecular dynamics to relax the resultant high energy structure. The activated form of Rh was then used as a structural template for development of a human 5-HT2A receptor model. Both the 5-HT2A receptor and Rh are members of the G-protein coupled receptor (GPCR) super-family. The resulting homology model of the receptor was then used for docking studies of compounds representing a cross-section of structural classes that activate the 5-HT2A receptor, including ergolines, tryptamines, and amphetamines. The ligand/receptor complexes that ensued were refined and the final binding orientations were observed to be compatible with much of the data acquired through both diversified ligand design and site directed mutagenesis.
利用牛视紫红质(Rh)晶体结构的活化形式构建了基于同源性的5-羟色胺2A受体(5-HT2A receptor)模型。通过11-顺式视黄醛(1)发色团的异构化实现Rh结构的计算机模拟活化,随后进行受限分子动力学以松弛产生的高能结构。然后将活化形式的Rh用作开发人5-HT2A受体模型的结构模板。5-HT2A受体和Rh均为G蛋白偶联受体(GPCR)超家族的成员。然后将所得的受体同源性模型用于对代表激活5-HT2A受体的结构类别横截面的化合物进行对接研究,这些化合物包括麦角灵、色胺和苯丙胺。对随后形成的配体/受体复合物进行优化,观察到最终的结合取向与通过多样化配体设计和定点诱变获得的许多数据相符。